These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 21071472

  • 1. FTY720-induced human pulmonary endothelial barrier enhancement is mediated by c-Abl.
    Wang L, Chiang ET, Simmons JT, Garcia JG, Dudek SM.
    Eur Respir J; 2011 Jul; 38(1):78-88. PubMed ID: 21071472
    [Abstract] [Full Text] [Related]

  • 2. Endothelial barrier protection by FTY720 under hyperglycemic condition: involvement of focal adhesion kinase, small GTPases, and adherens junction proteins.
    Sarai K, Shikata K, Shikata Y, Omori K, Watanabe N, Sasaki M, Nishishita S, Wada J, Goda N, Kataoka N, Makino H.
    Am J Physiol Cell Physiol; 2009 Oct; 297(4):C945-54. PubMed ID: 19657053
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pulmonary endothelial cell barrier enhancement by FTY720 does not require the S1P1 receptor.
    Dudek SM, Camp SM, Chiang ET, Singleton PA, Usatyuk PV, Zhao Y, Natarajan V, Garcia JG.
    Cell Signal; 2007 Aug; 19(8):1754-64. PubMed ID: 17475445
    [Abstract] [Full Text] [Related]

  • 5. Pulmonary endothelial cell barrier enhancement by novel FTY720 analogs: methoxy-FTY720, fluoro-FTY720, and β-glucuronide-FTY720.
    Camp SM, Chiang ET, Sun C, Usatyuk PV, Bittman R, Natarajan V, Garcia JG, Dudek SM.
    Chem Phys Lipids; 2015 Oct; 191():16-24. PubMed ID: 26272033
    [Abstract] [Full Text] [Related]

  • 6. Enhanced interaction between focal adhesion and adherens junction proteins: involvement in sphingosine 1-phosphate-induced endothelial barrier enhancement.
    Sun X, Shikata Y, Wang L, Ohmori K, Watanabe N, Wada J, Shikata K, Birukov KG, Makino H, Jacobson JR, Dudek SM, Garcia JG.
    Microvasc Res; 2009 May; 77(3):304-13. PubMed ID: 19323978
    [Abstract] [Full Text] [Related]

  • 7. FTY720 inhibits ceramide synthases and up-regulates dihydrosphingosine 1-phosphate formation in human lung endothelial cells.
    Berdyshev EV, Gorshkova I, Skobeleva A, Bittman R, Lu X, Dudek SM, Mirzapoiazova T, Garcia JG, Natarajan V.
    J Biol Chem; 2009 Feb 27; 284(9):5467-77. PubMed ID: 19119142
    [Abstract] [Full Text] [Related]

  • 8. FTY720 (s)-phosphonate preserves sphingosine 1-phosphate receptor 1 expression and exhibits superior barrier protection to FTY720 in acute lung injury.
    Wang L, Sammani S, Moreno-Vinasco L, Letsiou E, Wang T, Camp SM, Bittman R, Garcia JG, Dudek SM.
    Crit Care Med; 2014 Mar 27; 42(3):e189-99. PubMed ID: 24335440
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Phosphorylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vascular permeability.
    Sanchez T, Estrada-Hernandez T, Paik JH, Wu MT, Venkataraman K, Brinkmann V, Claffey K, Hla T.
    J Biol Chem; 2003 Nov 21; 278(47):47281-90. PubMed ID: 12954648
    [Abstract] [Full Text] [Related]

  • 11. "Pulmonary Endothelial Cell Barrier Enhancement by Novel FTY720 Analogs: Methoxy-FTY720, Fluoro-FTY720, and β-Glucuronide-FTY720".
    Camp SM, Chiang ET, Sun C, Usatyuk PV, Bittman R, Natarajan V, Garcia JG, Dudek SM.
    Chem Phys Lipids; 2016 Jan 21; 194():85-93. PubMed ID: 26496151
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Abl tyrosine kinase phosphorylates nonmuscle Myosin light chain kinase to regulate endothelial barrier function.
    Dudek SM, Chiang ET, Camp SM, Guo Y, Zhao J, Brown ME, Singleton PA, Wang L, Desai A, Arce FT, Lal R, Van Eyk JE, Imam SZ, Garcia JG.
    Mol Biol Cell; 2010 Nov 15; 21(22):4042-56. PubMed ID: 20861316
    [Abstract] [Full Text] [Related]

  • 14. Edaravone mimics sphingosine-1-phosphate-induced endothelial barrier enhancement in human microvascular endothelial cells.
    Omori K, Shikata Y, Sarai K, Watanabe N, Wada J, Goda N, Kataoka N, Shikata K, Makino H.
    Am J Physiol Cell Physiol; 2007 Nov 15; 293(5):C1523-31. PubMed ID: 17686998
    [Abstract] [Full Text] [Related]

  • 15. Functional characterization of sphingosine 1-phosphate receptor agonist in human endothelial cells.
    Butler J, Lana D, Round O, LaMontagne K.
    Prostaglandins Other Lipid Mediat; 2004 Jan 15; 73(1-2):29-45. PubMed ID: 15165029
    [Abstract] [Full Text] [Related]

  • 16. Phosphotyrosine protein dynamics in cell membrane rafts of sphingosine-1-phosphate-stimulated human endothelium: role in barrier enhancement.
    Zhao J, Singleton PA, Brown ME, Dudek SM, Garcia JG.
    Cell Signal; 2009 Dec 15; 21(12):1945-60. PubMed ID: 19755153
    [Abstract] [Full Text] [Related]

  • 17. Fingolimod (FTY720-P) Does Not Stabilize the Blood-Brain Barrier under Inflammatory Conditions in an in Vitro Model.
    Schuhmann MK, Bittner S, Meuth SG, Kleinschnitz C, Fluri F.
    Int J Mol Sci; 2015 Dec 10; 16(12):29454-66. PubMed ID: 26690412
    [Abstract] [Full Text] [Related]

  • 18. Role of FAK in S1P-regulated endothelial permeability.
    Belvitch P, Dudek SM.
    Microvasc Res; 2012 Jan 10; 83(1):22-30. PubMed ID: 21925517
    [Abstract] [Full Text] [Related]

  • 19. FTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function.
    Brinkmann V, Cyster JG, Hla T.
    Am J Transplant; 2004 Jul 10; 4(7):1019-25. PubMed ID: 15196057
    [Abstract] [Full Text] [Related]

  • 20. FTY720 and (S)-FTY720 vinylphosphonate inhibit sphingosine kinase 1 and promote its proteasomal degradation in human pulmonary artery smooth muscle, breast cancer and androgen-independent prostate cancer cells.
    Tonelli F, Lim KG, Loveridge C, Long J, Pitson SM, Tigyi G, Bittman R, Pyne S, Pyne NJ.
    Cell Signal; 2010 Oct 10; 22(10):1536-42. PubMed ID: 20570726
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.